Assessing biosafety using NGS-based tests requires a continuum of skills in molecular biology, biocomputing, virology, and quality systems.
Laurent Lafferrère
Advertisement
Laurent Lafferrère, PhD, is chief operating officer at PathoQuest.
Articles by Laurent Lafferrère
Advertisement
Latest Updated Articles
Challenges When Outsourcing Viral Safety ServicesPublished: May 16th 2021 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Strategic Shifts for Speed, Resilience, and Long-Term Sustainability in Biomanufacturing
2
Why Data Quality, Not Regulation, Is the True Barrier to AI in Biologics
3
Advances in Continuous Manufacturing, Drug Delivery Lead CPHI Pharma Awards 2025
4
EU Biopharma Strategy: Scaling Up to Tackle Funding Gaps and Drive Innovation
5
